Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country

Hikmat Abdel-Razeq,Baha Sharaf, Suhaib Khater, Huda Jafar Baidoun, Hira Bani Hani, Ayat Taqash, Osama El Khatib,Sarah Edaily,Mahmoud Abunasser,Faris Tamimi, Yosra Nabeel Al-Masri, Tamer Moh'd Waleed Al-Batsh, Anas Zayed, Tala Ghatasheh, Tala Radaideh

IMMUNOTARGETS AND THERAPY（2024）

Cited 0|Views0
No score
Key words
metastatic breast cancer,MBC,CDK4/6 inhibitors,ribociclib,aromatase inhibitors,fulvestrant
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined